Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia.

Authors :: Wimmer MR
Griffin M
Peterson-Weber A
Schulz LT
Hamel AG
Schwei RJ
Fong K
Burgess DR
Brett M
Hale CM
Holubar M
Jain R
Larry R
Spivak ES
Newland H
Njoku J
Postelnick M
Walraven C
Pulia MS
Source :: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 May; Vol. 45 (5), pp. 667-669. Date of Electronic Publication: 2023 Dec 28.
Publication Year :: 2024
Abstract: We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).

Subjects :: Humans
Inpatients
SARS-CoV-2
Diagnostic Techniques and Procedures
Anti-Bacterial Agents
COVID-19 Testing
COVID-19
Pneumonia

Full Text Access

Tools